Here are the 10-Q quarterly reports from Yijia Group Corp (YJGJ) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow YJGJ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full YJGJ filings page.
Yijia Group Corp reported stronger results for the quarter ended October 31, 2025, as its dietary supplement business drove growth. Revenue reached $427,115, up from $292,118, with gross profit of $260,803 and margin improving to 61%. For the first six months, revenue rose to $531,014, a 33% increase, while the net loss narrowed to $10,491 from $22,564 and operating cash flow turned into a $476,471 inflow.
The company ended the quarter with $1,259,281 in cash and total assets of $2,336,244 against $438,051 in current liabilities and no long-term debt. Results are highly concentrated, with a few U.S. customers contributing over 60% of revenue and one vendor providing all purchases, and management continues to disclose material weaknesses in internal controls due to the absence of an independent audit committee.
YIJIA GROUP CORP. (YJGJ) Q1 Highlights The filing shows total revenue of $108,477 for the period, producing reported gross profit amounts of $68,781 and $73,173 in comparative periods. The company recorded a loss before income tax of $32,440 (and a prior period loss of $45,414). Share capital outstanding totaled 25,012,270 shares. Management applied a full valuation allowance against deferred tax assets, with a net change in that allowance of $17,397. The company reports significant customer and vendor concentrations: one customer ("Customer B") accounted for 100% of revenues amounting to $108,477 and a single vendor represented 54% of purchases ($114,598). Cash balances include material uninsured amounts of $468,926 and $301,267. The company issued share-based compensation arrangements (60,000 shares to the CFO at $0.05 fair value) with common stock issuable of $3,000. Financial statements are unaudited and certain schedules (allowances for credit losses and obsolete inventory) show no recorded reserves.